Centers for Disease Control and Prevention 1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO
Page last reviewed: October, 2014
Page last updated: October, 2014
Partner Management and Public Health Measures
Male sex partners of a woman with PID should be examined and treated if they had sexual contact with the woman during the 60 days preceding onset of symptoms. If a patient’s last sexual intercourse was >60 days before onset of symptoms or diagnosis, the patient’s most recent sex partner should be treated. Such evaluation and treatment are imperative because of the risk for reinfection and the strong likelihood of gonococcal or chlamydial infection in the sex partner.
Male partners of women who have PID caused by C. trachomatis or N. gonorrhoeae are often asymptomatic.
Sex partners should be treated empirically with regimens effective against both C. trachomatis and N. gonorrhoeae, regardless of the apparent etiology of PID or pathogens isolated from the infected woman.
Laws and regulations in all states require that persons with gonorrhea or chlamydia be reported to public health authorities by clinicians, labs, or both. Click here for links to state and local public health departments.
Prevention of chlamydial infection by screening and treating at-risk women reduces the incidence of PID. Chlamydia screening recommendations include annual screening for:
Sexually active women age 25 and younger
Sexually active women over age 25 at high risk
Pregnant women in the first trimester, or at the first prenatal visit if after the first trimester
Any patient diagnosed with another STD
Screening for and treatment of BV prior to upper reproductive tract invasive
or surgical procedures (e.g., abortion or hysterectomy) is a prevention
strategy recommended by some experts.